Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection
dc.contributor.author | Riou, Catherine | en_ZA |
dc.contributor.author | Du Bruyn, Elsa | en_Za |
dc.contributor.author | Stek, Cari | en_ZA |
dc.contributor.author | Daroowala, Remy | en_ZA |
dc.contributor.author | Goliath, Rene T. | en_ZA |
dc.contributor.author | Abrahams, Fatima | en_ZA |
dc.contributor.author | Said-Hartley, Qonita | en_ZA |
dc.date.accessioned | 2023-03-27T09:20:49Z | en_ZA |
dc.date.available | 2023-03-27T09:20:49Z | en_ZA |
dc.date.issued | 2021-05 | en_ZA |
dc.description | CITATION: Riou, C. et al. 2021. Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. The Journal of Clinical Investigation 131(12):e149125. doi.10.1172/JCI149125. | en_ZA |
dc.description | The original publication is available at: jci.org | en_ZA |
dc.description.abstract | T cells are involved in control of coronavirus disease 2019 (COVID-19), but limited knowledge is available on the relationship between antigen-specific T cell response and disease severity. Here, we used flow cytometry to assess the magnitude, function, and phenotype of SARS coronavirus 2–specific (SARS-CoV-2–specific) CD4+ T cells in 95 hospitalized COVID-19 patients, 38 of them being HIV-1 and/or tuberculosis (TB) coinfected, and 38 non–COVID-19 patients. We showed that SARSCoV- 2–specific CD4+ T cell attributes, rather than magnitude, were associated with disease severity, with severe disease being characterized by poor polyfunctional potential, reduced proliferation capacity, and enhanced HLA-DR expression. Moreover, HIV-1 and TB coinfection skewed the SARS-CoV-2 T cell response. HIV-1–mediated CD4+ T cell depletion associated with suboptimal T cell and humoral immune responses to SARS-CoV-2, and a decrease in the polyfunctional capacity of SARSCoV- 2–specific CD4+ T cells was observed in COVID-19 patients with active TB. Our results also revealed that COVID-19 patients displayed reduced frequency of Mycobacterium tuberculosis–specific CD4+ T cells, with possible implications for TB disease progression. These results corroborate the important role of SARS-CoV-2–specific T cells in COVID-19 pathogenesis and support the concept of altered T cell functions in patients with severe disease. | en_ZA |
dc.description.version | Publisher’s version | en_ZA |
dc.format.extent | 16 pages | en_ZA |
dc.identifier.citation | Riou, C. et al. 2021. Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection. The Journal of Clinical Investigation 131(12):e149125. doi.10.1172/JCI149125. | en_ZA |
dc.identifier.issn | 0021-9738 (print) | en_ZA |
dc.identifier.issn | 1558-8238 (online) | en_ZA |
dc.identifier.other | doi.10.1172/JCI149125 | en_ZA |
dc.identifier.uri | http://hdl.handle.net/10019.1/126718 | en_ZA |
dc.language.iso | en_ZA | en_ZA |
dc.publisher | American Society for Clinical Investigation | en_ZA |
dc.rights.holder | Authors retain copyright | en_ZA |
dc.subject | COVID-19 (Disease) | en_ZA |
dc.subject | Immune response -- Molecular aspects | en_ZA |
dc.subject | Cellular immune response | en_ZA |
dc.subject | T cells -- Receptors | en_ZA |
dc.subject | Communicable diseases | en_ZA |
dc.subject | UCTD | en_ZA |
dc.title | Relationship of SARS-CoV-2–specific CD4 response to COVID-19 severity and impact of HIV-1 and tuberculosis coinfection | en_ZA |
dc.type | Article | en_ZA |